Vipidia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vipidia, covering 2023-07-21 to 2023-07-21. Get the full timeline:
Most recent: EMA Authorised: Vipidia (alogliptin) — Takeda Pharma A/S
1 regulatory and trial event tracked for Vipidia, covering 2023-07-21 to 2023-07-21. Get the full timeline:
Most recent: EMA Authorised: Vipidia (alogliptin) — Takeda Pharma A/S